CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Custopharm, Inc. v. Fresenius Kabi USA, LLC

6:21-cv-00148

Overview

Case Number 6:21-cv-00148
Filing Date 2021-02-16
Status Terminated
Termination Date 2021-03-26
Court District Court, W.D. Texas (txwd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement

Parties

Defendant

Fresenius Kabi USA, LLC Operating Company

Represented By

2 Attorneys Listed

Kevin S. Kudlac

Radulescu LLP

Tel: +1 (512) 656-5743

100 Congress Aveue, Ste. 2000

Cabrach J. Connor

Connor Lee & Shumaker PLLC

Tel: +1 (512) 767-8341

609 Castle Ridge Road, Suite 450

Plaintiff

Custopharm, Inc. Operating Company

Represented By

3 Attorneys Listed

Steven Eric Feldman

Hahn, Loeser & Parks, LLP

Tel: +1 (312) 637-3010
Fax: +1 (312) 637-3011

200 West Madison Street, Suite 2700, Chicago, IL 60606

Sherry Lee Rollo

Hahn, Loeser & Parks, LLP

Tel: +1 (312) 637-3020
Fax: +1 (312) 637-3021

200 West Madison Street, Suite 2700, Chicago, IL 60606

Travis C. Barton

McGinnis, Lochridge LLP

Tel: +1 (512) 495-6000
Fax: +1 (512) 495-6093

1111 W. 6th Street, Suite 400, Austin, TX 78703

Court & Judges

Court

District Court, W.D. Texas (txwd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): πŸ‡¨πŸ‡¦ Canada πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9782376
Levothyroxine liquid formulations
Filed: 2016-12-01
Issued: 2017-10-10
Active (10.0 yrs remaining)
Expires: 2036-12-01
US10398669
Levothyroxine liquid formulations
Filed: 2017-09-11
Issued: 2019-09-03
Active (10.8 yrs remaining)
Expires: 2037-09-11

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Docket Entries

(3 total)

REQUEST FOR ISSUANCE OF SUMMONS by Custopharm, Inc.. (Fresenius Kabi USA, LLC) (Barton, Travis) (Entered: 02/16/2021)

Entry #2 • 2021-02-16
PACER Document
Pleading / Complaint

ANSWER to 1 Complaint,,,,, COUNTERCLAIM against Custopharm, Inc. by Fresenius Kabi USA, LLC.(Connor, Cabrach) (Entered: 03/15/2021)

Entry #12 • 2021-03-15
PACER Document
Court Order

Joint MOTION to Consolidate Cases (and designate lead case: Fresenius Kabi USA, LLC v. Custopharm, Inc., Case No. 6:21-cv-164-LY) by Fresenius Kabi USA, LLC. (Attachments: # 1 Proposed Order)(Connor, Cabrach) (Entered: 03/19/2021)

Entry #13 • 2021-03-19
PACER Document

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc